Bakhu Holdings Corp
OTC:BKUH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bakhu Holdings Corp
Short-Term Debt
Bakhu Holdings Corp
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bakhu Holdings Corp
OTC:BKUH
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Short-Term Debt
$6.5B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
85%
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Short-Term Debt
$284m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Short-Term Debt
$157m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bakhu Holdings Corp
Glance View
Bakhu Holdings Corp. engages in the planning to exploit licenses that acquires in the bio-pharmacy field, specifically in the cell-extraction sector. The company is headquartered in Long Beach, California. The company went IPO on 2009-06-22. The firm is engaged in the production, manufacturing and selling cannabis-related by-products and the Caribbean for medical, food additive, and recreational uses. The firm operates in cannabinoids industry exclusively in North and Central America. The firm completes a full-scale demonstration of the commercial viability of the technology, namely Efficacy Demonstration. The firm hold a license from Cell Science Holding Ltd., an affiliate (Cell Science), to plant cell replication technology and related proprietary equipment.
See Also
What is Bakhu Holdings Corp's Short-Term Debt?
Short-Term Debt
0
USD
Based on the financial report for Apr 30, 2024, Bakhu Holdings Corp's Short-Term Debt amounts to 0 USD.
